Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation
Acute lung injury (ALI) is a serious clinical syndrome with a high rate of mortality. The activation of inflammation is well-recognized as a vital factor in the pathogenesis of lipopolysaccharide (LPS)-induced ALI. Therefore, suppression of the inflammatory response could be an ideal strategy to pre...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000700605&lng=en&tlng=en |
_version_ | 1819207108303781888 |
---|---|
author | Jia Wang Shi Ming Fan Jiong Zhang |
author_facet | Jia Wang Shi Ming Fan Jiong Zhang |
author_sort | Jia Wang |
collection | DOAJ |
description | Acute lung injury (ALI) is a serious clinical syndrome with a high rate of mortality. The activation of inflammation is well-recognized as a vital factor in the pathogenesis of lipopolysaccharide (LPS)-induced ALI. Therefore, suppression of the inflammatory response could be an ideal strategy to prevent ALI. Epigallocatechin-3-gallate (EGCG), mainly from green tea, has been shown to have an anti-inflammatory effect. The aim of the study was to explore whether EGCG alleviates inflammation in sepsis-related ALI. Male BALB/C mice were treated with EGCG (10 mg/kg) intraperitoneally (ip) 1 h before LPS injection (10 mg/kg, ip). The results showed that EGCG attenuated LPS-induced ALI as it decreased the changes in blood gases and reduced the histological lesions, wet-to-dry weight ratios, and myeloperoxidase (MPO) activity. In addition, EGCG significantly decreased the expression of pro-inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in the lung, serum, and bronchoalveolar lavage fluid, and alleviated the expression of TLR-4, MyD88, TRIF, and p-p65 in the lung tissue. In addition, it increased the expression of IκB-α and had no influence on the expression of p65. Collectively, these results demonstrated the protective effects of EGCG against LPS-induced ALI in mice through its anti-inflammatory effect that may be attributed to the suppression of the activation of TLR 4-dependent NF-κB signaling pathways. |
first_indexed | 2024-12-23T05:18:15Z |
format | Article |
id | doaj.art-ffded33c1e9b4041a8e5d65f6ce5df32 |
institution | Directory Open Access Journal |
issn | 1414-431X |
language | English |
last_indexed | 2024-12-23T05:18:15Z |
publisher | Associação Brasileira de Divulgação Científica |
record_format | Article |
series | Brazilian Journal of Medical and Biological Research |
spelling | doaj.art-ffded33c1e9b4041a8e5d65f6ce5df322022-12-21T17:58:47ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X52710.1590/1414-431x20198092S0100-879X2019000700605Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activationJia WangShi Ming FanJiong ZhangAcute lung injury (ALI) is a serious clinical syndrome with a high rate of mortality. The activation of inflammation is well-recognized as a vital factor in the pathogenesis of lipopolysaccharide (LPS)-induced ALI. Therefore, suppression of the inflammatory response could be an ideal strategy to prevent ALI. Epigallocatechin-3-gallate (EGCG), mainly from green tea, has been shown to have an anti-inflammatory effect. The aim of the study was to explore whether EGCG alleviates inflammation in sepsis-related ALI. Male BALB/C mice were treated with EGCG (10 mg/kg) intraperitoneally (ip) 1 h before LPS injection (10 mg/kg, ip). The results showed that EGCG attenuated LPS-induced ALI as it decreased the changes in blood gases and reduced the histological lesions, wet-to-dry weight ratios, and myeloperoxidase (MPO) activity. In addition, EGCG significantly decreased the expression of pro-inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in the lung, serum, and bronchoalveolar lavage fluid, and alleviated the expression of TLR-4, MyD88, TRIF, and p-p65 in the lung tissue. In addition, it increased the expression of IκB-α and had no influence on the expression of p65. Collectively, these results demonstrated the protective effects of EGCG against LPS-induced ALI in mice through its anti-inflammatory effect that may be attributed to the suppression of the activation of TLR 4-dependent NF-κB signaling pathways.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000700605&lng=en&tlng=enEpigallocatechin-3-gallateAcute lung injuryInflammation |
spellingShingle | Jia Wang Shi Ming Fan Jiong Zhang Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation Brazilian Journal of Medical and Biological Research Epigallocatechin-3-gallate Acute lung injury Inflammation |
title | Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation |
title_full | Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation |
title_fullStr | Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation |
title_full_unstemmed | Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation |
title_short | Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation |
title_sort | epigallocatechin 3 gallate ameliorates lipopolysaccharide induced acute lung injury by suppression of tlr4 nf κb signaling activation |
topic | Epigallocatechin-3-gallate Acute lung injury Inflammation |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000700605&lng=en&tlng=en |
work_keys_str_mv | AT jiawang epigallocatechin3gallateameliorateslipopolysaccharideinducedacutelunginjurybysuppressionoftlr4nfkbsignalingactivation AT shimingfan epigallocatechin3gallateameliorateslipopolysaccharideinducedacutelunginjurybysuppressionoftlr4nfkbsignalingactivation AT jiongzhang epigallocatechin3gallateameliorateslipopolysaccharideinducedacutelunginjurybysuppressionoftlr4nfkbsignalingactivation |